A citation-based method for searching scientific literature

Kara L Britt, Jack Cuzick, Kelly-Anne Phillips. Nat Rev Cancer 2020
Times Cited: 119







List of co-cited articles
189 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
23

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
16

Breast Cancer Treatment: A Review.
Adrienne G Waks, Eric P Winer. JAMA 2019
10

Breast cancer.
Nadia Harbeck, Frédérique Penault-Llorca, Javier Cortes, Michael Gnant, Nehmat Houssami, Philip Poortmans, Kathryn Ruddy, Janice Tsang, Fatima Cardoso. Nat Rev Dis Primers 2019
679
9

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
6

Breast cancer statistics, 2019.
Carol E DeSantis, Jiemin Ma, Mia M Gaudet, Lisa A Newman, Kimberly D Miller, Ann Goding Sauer, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2019
6

Breast cancer: Biology, biomarkers, and treatments.
Khadijeh Barzaman, Jafar Karami, Zeinab Zarei, Aysooda Hosseinzadeh, Mohammad Hossein Kazemi, Shima Moradi-Kalbolandi, Elahe Safari, Leila Farahmand. Int Immunopharmacol 2020
75
8

Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017.
Na Li, Yujiao Deng, Linghui Zhou, Tian Tian, Si Yang, Ying Wu, Yi Zheng, Zhen Zhai, Qian Hao, Dingli Song,[...]. J Hematol Oncol 2019
133
5

Breast cancer in China.
Lei Fan, Kathrin Strasser-Weippl, Jun-Jie Li, Jessica St Louis, Dianne M Finkelstein, Ke-Da Yu, Wan-Qing Chen, Zhi-Ming Shao, Paul E Goss. Lancet Oncol 2014
864
5

Breast cancer.
Nadia Harbeck, Michael Gnant. Lancet 2017
915
5

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.
Yingyao Zhou, Bin Zhou, Lars Pache, Max Chang, Alireza Hadj Khodabakhshi, Olga Tanaseichuk, Christopher Benner, Sumit K Chanda. Nat Commun 2019
5

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.
Zefang Tang, Chenwei Li, Boxi Kang, Ge Gao, Cheng Li, Zemin Zhang. Nucleic Acids Res 2017
5

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
5

Risk Factors and Preventions of Breast Cancer.
Yi-Sheng Sun, Zhao Zhao, Zhang-Nv Yang, Fang Xu, Hang-Jing Lu, Zhi-Yong Zhu, Wen Shi, Jianmin Jiang, Ping-Ping Yao, Han-Ping Zhu. Int J Biol Sci 2017
314
4


Personalized early detection and prevention of breast cancer: ENVISION consensus statement.
Nora Pashayan, Antonis C Antoniou, Urska Ivanus, Laura J Esserman, Douglas F Easton, David French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans,[...]. Nat Rev Clin Oncol 2020
66
6

Breast Cancer Epidemiology, Prevention, and Screening.
Stella Winters, Charmaine Martin, Daniel Murphy, Navkiran K Shokar. Prog Mol Biol Transl Sci 2017
173
4

Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study.
Emily Heer, Andrew Harper, Noah Escandor, Hyuna Sung, Valerie McCormack, Miranda M Fidler-Benaoudia. Lancet Glob Health 2020
131
4

TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.
Taiwen Li, Jingyu Fan, Binbin Wang, Nicole Traugh, Qianming Chen, Jun S Liu, Bo Li, X Shirley Liu. Cancer Res 2017
4

Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets.
Yiran Liang, Hanwen Zhang, Xiaojin Song, Qifeng Yang. Semin Cancer Biol 2020
139
4

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.
Aditya Bardia, Ingrid A Mayer, Linda T Vahdat, Sara M Tolaney, Steven J Isakoff, Jennifer R Diamond, Joyce O'Shaughnessy, Rebecca L Moroose, Alessandro D Santin, Vandana G Abramson,[...]. N Engl J Med 2019
306
4

HER2-positive advanced breast cancer treatment in 2020.
Marcelle G Cesca, Lucas Vian, Sofia Cristóvão-Ferreira, Noam Pondé, Evandro de Azambuja. Cancer Treat Rev 2020
30
13


Global cancer statistics, 2012.
Lindsey A Torre, Freddie Bray, Rebecca L Siegel, Jacques Ferlay, Joannie Lortet-Tieulent, Ahmedin Jemal. CA Cancer J Clin 2015
4

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
4

Cancer statistics for the year 2020: An overview.
Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram, Donald M Parkin, Marion Piñeros, Ariana Znaor, Freddie Bray. Int J Cancer 2021
450
4

Breast cancer prevention in high-risk women.
Mangesh A Thorat, Rajeshkumar Balasubramanian. Best Pract Res Clin Obstet Gynaecol 2020
49
8


Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis.
S G Smith, I Sestak, A Forster, A Partridge, L Side, M S Wolf, R Horne, J Wardle, J Cuzick. Ann Oncol 2016
138
3

Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic.
L S Donnelly, D G Evans, J Wiseman, J Fox, R Greenhalgh, J Affen, I Juraskova, P Stavrinos, S Dawe, J Cuzick,[...]. Br J Cancer 2014
60
5

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.
Jack Cuzick, Ivana Sestak, Bernardo Bonanni, Joseph P Costantino, Steve Cummings, Andrea DeCensi, Mitch Dowsett, John F Forbes, Leslie Ford, Andrea Z LaCroix,[...]. Lancet 2013
279
3

Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches.
Julia Beermann, Maria-Teresa Piccoli, Janika Viereck, Thomas Thum. Physiol Rev 2016
951
3

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.
Jack Cuzick, Ivana Sestak, Simon Cawthorn, Hisham Hamed, Kaija Holli, Anthony Howell, John F Forbes. Lancet Oncol 2015
246
3



Primary and secondary prevention of breast cancer.
Agnieszka Kolak, Marzena Kamińska, Katarzyna Sygit, Agnieszka Budny, Dariusz Surdyka, Bożena Kukiełka-Budny, Franciszek Burdan. Ann Agric Environ Med 2017
69
4

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
3

Physical activity, hormone replacement therapy and breast cancer risk: A meta-analysis of prospective studies.
Cécile Pizot, Mathieu Boniol, Patrick Mullie, Alice Koechlin, Magali Boniol, Peter Boyle, Philippe Autier. Eur J Cancer 2016
84
3


Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.
Paige Maas, Myrto Barrdahl, Amit D Joshi, Paul L Auer, Mia M Gaudet, Roger L Milne, Fredrick R Schumacher, William F Anderson, David Check, Subham Chattopadhyay,[...]. JAMA Oncol 2016
171
3

Prevalence and mutational determinants of high tumor mutation burden in breast cancer.
R Barroso-Sousa, E Jain, O Cohen, D Kim, J Buendia-Buendia, E Winer, N Lin, S M Tolaney, N Wagle. Ann Oncol 2020
97
3

LinkedOmics: analyzing multi-omics data within and across 32 cancer types.
Suhas V Vasaikar, Peter Straub, Jing Wang, Bing Zhang. Nucleic Acids Res 2018
764
3

UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.
Darshan S Chandrashekar, Bhuwan Bashel, Sai Akshaya Hodigere Balasubramanya, Chad J Creighton, Israel Ponce-Rodriguez, Balabhadrapatruni V S K Chakravarthi, Sooryanarayana Varambally. Neoplasia 2017
3

Trastuzumab emtansine for HER2-positive advanced breast cancer.
Sunil Verma, David Miles, Luca Gianni, Ian E Krop, Manfred Welslau, José Baselga, Mark Pegram, Do-Youn Oh, Véronique Diéras, Ellie Guardino,[...]. N Engl J Med 2012
3

Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial.
K Kalinsky, J R Diamond, L T Vahdat, S M Tolaney, D Juric, J O'Shaughnessy, R L Moroose, I A Mayer, V G Abramson, D M Goldenberg,[...]. Ann Oncol 2020
36
8

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, Michael Lush, Laura Fachal, Andrew Lee, Jonathan P Tyrer, Ting-Huei Chen, Qin Wang, Manjeet K Bolla,[...]. Am J Hum Genet 2019
328
3

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.
Claudia Allemani, Tomohiro Matsuda, Veronica Di Carlo, Rhea Harewood, Melissa Matz, Maja Nikšić, Audrey Bonaventure, Mikhail Valkov, Christopher J Johnson, Jacques Estève,[...]. Lancet 2018
3

Awareness and current knowledge of breast cancer.
Muhammad Akram, Mehwish Iqbal, Muhammad Daniyal, Asmat Ullah Khan. Biol Res 2017
302
3

clusterProfiler: an R package for comparing biological themes among gene clusters.
Guangchuang Yu, Li-Gen Wang, Yanyan Han, Qing-Yu He. OMICS 2012
3

Novel HER2-targeted therapies for HER2-positive metastatic breast cancer.
Siddharth Kunte, Jame Abraham, Alberto J Montero. Cancer 2020
30
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.